Liraglutide: all 338 studies that test it

Page 2 of 4. Open to participants first (20), then studies with results posted, then the rest; newest registration first within each.

• Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and MetforminCompletedNCT01388361Phase 3Results posted
• Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)CompletedNCT01373450Phase 1Results posted
• Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 DiabetesCompletedNCT01336023Phase 3Results posted
• Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - DiabetesCompletedNCT01272232Phase 3Results posted
• Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetesCompletedNCT01272219Phase 3Results posted
• Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)CompletedNCT01234649Phase 3Results posted
• Cooperation of Insulin and GLP-1 on Myocardial Glucose UptakeCompletedNCT01232946Not applicableResults posted
• Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell TransplantationTerminatedNCT01206101Phase 2Results posted
• Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome ResultsCompletedNCT01179048Phase 3Results posted
• Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - MaintenanceCompletedNCT00781937Phase 3Results posted
• The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes MellitusCompletedNCT00700817Phase 3Results posted
• A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and LiraglutideCompletedNCT00696657Phase 2Results posted
• The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes MellitusCompletedNCT00620282Phase 3Results posted
• Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00614120Phase 3Results posted
• Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00518882Phase 3Results posted
• The Effect of Liraglutide on Body Weight in Obese Subjects Without DiabetesCompletedNCT00422058Phase 2Results posted
• Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00395746Phase 3Results posted
• Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00393718Phase 3Results posted
• To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given TogetherCompletedNCT00318461Phase 3Results posted
• To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1cTerminatedNCT00294723Phase 3Results posted
• Use of Liraglutide in Children Aged 6 to 12 Years With Severe ObesityActive, not recruitingNCT07590219Phase 4
• Research on Timing of Liraglutide Therapy in Patients With Obesity After Metabolic SurgeryCompletedNCT07374445Phase 4
• A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and OsteoarthritisCompletedNCT07225829Phase 2
• Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 AgonistsCompletedNCT06818292Not applicable
• Liraglutide Effectiveness in Preoperative Weight-loss for Bariatric-metabolic SurgeryCompletedNCT06201819Phase 4
• Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory IssuesSuspendedNCT06171152Early Phase 1
• Effect of Liraglutide in Obese Women With Polycystic Ovary SyndromeCompletedNCT05965908Phase 3
• Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 AnalogueStatus unknownNCT05767255Phase 3
• Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes MellitusCompletedNCT05467514Phase 3
• Obesity Treatment to Improve DiabetesCompletedNCT05390307Not applicable
• Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic InpatientsCompletedNCT05360537Phase 4
• Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes MellitusCompletedNCT05360147Phase 3
• LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 DiabetesCompletedNCT05313529Not applicable
• Effect of Liraglutide on Weight Loss in Patients Who Have Undergone Revisional Bariatric Surgeries.Status unknownNCT05285397Not applicable
• Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight LossStatus unknownNCT05268627Not applicable
• A Randomized Phase 1 Study of Liralutide Injection in Healthy Chinese SubjectsCompletedNCT05225974Phase 1
• Human Bioequivalence Test of Liraglutide InjectionCompletedNCT05029076Phase 1
• A Study in Men With Overweight to Test How Well Different Doses of BI 1820237 Are Tolerated When Given as an Injection Alone or in Combination With LiraglutideCompletedNCT04903509Phase 1
• The Effect and the Pharmacogenomics Study of Liraglutide in Obese PatientsWithdrawnNCT04839237Phase 2
• Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry?CompletedNCT04781998Phase 4
• SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With ObesityActive, not recruitingNCT04775082Phase 3
• Liraglutide Plus Megestrol Acetate in Endometrial Atypical HyperplasiaWithdrawnNCT04683237Phase 2/3
• Targeting Beta-cell Failure in Lean Patients With Type 2 DiabetesCompletedNCT04657939Phase 4
• Liraglutide for Low-responders After Bariatric SurgeryWithdrawnNCT04643301Not applicable
• The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight PatientsCompletedNCT04605861Phase 3
• Study of the Cardiometabolic Effects of Obesity PharmacotherapyStatus unknownNCT04575194Phase 4
• Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" TrialCompletedNCT04535960Phase 2
• Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis PatientsStatus unknownNCT04529278Phase 2
• Gut Microbiome Changes Following Liraglutide Treatment in Obese Subjects or Overweight Subjects With Co-morbiditiesStatus unknownNCT04525300Phase 3
• Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbiditiesStatus unknownNCT04487743Phase 3
• Laparocopic Sleeve Gastrectomy With or Without Liraglutide in Obese PatientsCompletedNCT04325581Phase 3
• Liraglutide in the Prevention of Type 2 Diabetes After Gestational DiabetesCompletedNCT04324229Not applicable
• Effect of Liraglutide vs CPAP on Cardiometabolic Outcomes in Obstructive Sleep ApneaCompletedNCT04186494Not applicable
• Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial DiseaseStatus unknownNCT04146155Phase 4
• Clinical Study on the Improvement of Diabetic Neuropathic Pain by LiraglutideStatus unknownNCT04137328Not applicable
• Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie DietStatus unknownNCT04122716Phase 4
• Effect of Liraglutide on the Metabolic Profile in Patients With Type 2 Diabetes and Cardiovascular DiseaseWithdrawnNCT04057261Phase 3
• Effect of Liraglutide on Microbiome in ObesityStatus unknownNCT04046822Phase 4
• The Effect of Liraglutide on the GITStatus unknownNCT04008290Phase 4
• Treatment of Bile Acid Malabsorption With LiraglutideCompletedNCT03955575Phase 4
• Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes MellitusStatus unknownNCT03948347Not applicable
• Liraglutide Effect in Atrial FibrillationActive, not recruitingNCT03856632Phase 4
• To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue ReactivityCompletedNCT03795701Not applicable
• Effects of Liraglutide on the Cognitive Function in Patients With Type 2 Diabetes MellitusCompletedNCT03707171Phase 3
• The Use of Liraglutide in Brain DeathCompletedNCT03672812Phase 3
• Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese PatientsStatus unknownNCT03671733Phase 3
• Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1DCompletedNCT03632759Early Phase 1
• Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.CompletedNCT03619330Phase 4
• Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mgCompletedNCT03534310Not applicable
• The Effect of Liraglutide on Pancreatic Hormones and Its SizeCompletedNCT03520062Not applicable
• Effects of Liraglutide in Chronic Obstructive Pulmonary DiseaseCompletedNCT03466021Phase 4
• Effect of Liraglutide on Vascular Inflammation in Type-2 DiabetesCompletedNCT03449654Phase 4
• The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 DiabetesStatus unknownNCT03426085Phase 2
• Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II DiabetesStatus unknownNCT03421119Phase 3
• Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)WithdrawnNCT03371862Phase 2
• The Effect of a Liraglutide on IVF in Obese PCOSCompletedNCT03353948Phase 4
• Evaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 ResponseCompletedNCT03341429Phase 4
• A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese SubjectsCompletedNCT03292185Phase 1
• Antidiabetic Effects on Intrahepatic FatCompletedNCT03068065Phase 4
• Short Term Weight Loss With Liraglutide and Metformin in Infertile Obese PCOS PatientsCompletedNCT03034941Phase 4
• Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes MellitusStatus unknownNCT03011008Phase 4
• Saxenda: Underlying Mechanisms and Clinical OutcomesActive, not recruitingNCT02944500Phase 4
• Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight MaintenanceCompletedNCT02931383Phase 4
• Clinical Study of Liraglutide in Improving Cardiac Function for Patients With Ischemic CardiomyopathyStatus unknownNCT02930265Not applicable
• Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight MaintenanceCompletedNCT02928679Phase 4
• Biomarkers in Obese Patients With Knee Osteoarthritis; Weight MaintenanceCompletedNCT02928614Phase 4
• Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial FatWithdrawnNCT02920190Phase 4
• Changes in Skin Autoflouresence Following Weight Loss and Maintenance Using Liraglutide in Knee OsteoarthritisCompletedNCT02910570Phase 4
• Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of ObesityCompletedNCT02909933Phase 4
• Incretin-based Therapy in Early Diagnosed Type 1 DiabetesCompletedNCT02908087Phase 2
• Liraglutide 3 mg for Knee OsteoarthritisCompletedNCT02905864Phase 4
• Incretin-based Therapy in Late Preclinical Type 1 DiabetesCompletedNCT02898506Phase 2
• HbA1c Variability in Type II DiabetesActive, not recruitingNCT02879409Not applicable
• Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With ObesityCompletedNCT02870231Phase 1
• Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in Type 2 DiabetesCompletedNCT02832999Phase 4
• Effect of Liraglutide on Clock GenesStatus unknownNCT02783196Not applicable
• Liraglutide for HIV-associated Neurocognitive DisorderTerminatedNCT02743598Phase 4
• Effect of Liraglutide on Fatty Liver Content and Lipoprotein MetabolismTerminatedNCT02721888Phase 4
• Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in HumansStatus unknownNCT02718950Phase 3
• A Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects.CompletedNCT02717858Phase 1

← Liraglutide overview